Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Completed · Not applicable
Conditions studied: Endometrial Cancer
In brief
Multicenter, non-randomized, feasibility study to evaluate the treatment and assess acute safety of the FDA Cleared Axxent Electronic Brachytherapy System and vaginal applicator for intracavitary vaginal cuff treatment according to the physician's current standard of care.
Key facts
- Study ID
- NCT01045187
- Run by
- Xoft, Inc.
- People needed
- 15
- Starts
- 2008-10-01
- Expected to finish
- 2010-04-01
- Last updated by the study team
- 2012-08-01
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Most types of endometrial (uterine) cancer Stage I and Stage II (see exclusion criteria below)
- Post hysterectomy
You may not qualify if…
- Endometrial (uterine) cancer Stage IA Grade 1
- Scleroderma
- Collagen vascular disease
- Active Lupus
Where it is running
- Cancer Treatment Services Arizona — Casa Grande, Arizona, United States
- Southwest Oncology Center — Phoenix, Arizona, United States
- Beverly Oncology & Imaging Medical Center, Inc — Montebello, California, United States
- Swedish Covenant Hospital — Chicago, Illinois, United States
- Little Company of Mary Hospital — Evergreen Park, Illinois, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.